Beta-blockers and Airways Disease

A prospective observational study of cardiology patients to estimate the prevalence of coexistant obstructive airways disease using spirometry, to document cardiologists' current prescribing practices with regard to beta-blocker medications and to measure both short and long term adverse beta-blocker effects in terms of spirometry, respiratory symptoms, exacerbation rates and hospital admissions.

Status

Completed

Phases

Unknown

Study type

Observational

Source

ANZCTR

Registry ID

ACTRN12605000148673

Enrollment

Registered

2005-08-15

Start date

2003-04-04

Completion date

Unknown

Last updated

2020-01-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

The study intervention comprised an interviewer-administered questionnaire and measurement of spirometry. Specifically at time of enrolment, prior to hospital discharge, at 6 months and 12 months respiratory symptoms, measures of spirometry and bronchodilator response (using Salbutamol 5mg and Ipratropium bromide 0.5 mg combined via a nebuliser for assessment of bronchodilator response), exacerbation rates and hospital admission rates were recorded.

Eligibility

Sex/Gender

All

Age

0 to No maximum

Healthy volunteers

Inclusion criteria

Acceptance for hospital admission under the cardiology unit of Royal Pince Alfred Hospital for assessment and treatment of an acute cardiac condition

Exclusion criteria

No exclusion criteria

Outcome results